<?xml version="1.0" encoding="UTF-8"?>
<p>Culture media and supplements were obtained from Gibco (Life Technologies, Paisley, United Kingdom) unless indicated otherwise. Virus stocks of RVFV strain Clone 13 (
 <xref rid="bib51" ref-type="bibr">Muller et al., 1995</xref>) and SBV strain NL-F6 (
 <xref rid="bib59" ref-type="bibr">Van Der Poel et al., 2014</xref>) were obtained after infections at low multiplicity of infection (0.01) of Vero E6 cells (ATCC CRL-1586, Teddington, United Kingdom). Vero cells were maintained in Eagle's minimal essential medium (EMEM) supplemented with 1% nonessential amino acids (NEAA), 1% antibiotic/antimycotic (a/a) and 5% foetal bovine serum (FBS), at 37Â°C with 5% CO
 <sub>2</sub>. Cells were regularly tested and were mycoplasma free.
</p>
